CIAM
RLAY icon

Caitong International Asset Management’s Relay Therapeutics RLAY Stock Holding History

Caitong International Asset Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$412 Sell
22
-2,768
-99% -$40.2K ﹤0.01% 1806
2026
Q1 		$27.8K Sell
2,790
-10,849
-80% -$97.1K 0.01% 934
2025
Q4 		$115K Buy
+13,639
New +$97.3K 0.03% 365
2025
Q2 		– Sell
-940
Closed -$2.46K – 2405
2025
Q1 		$2.46K Buy
940
+877
+1,392% +$3.44K ﹤0.01% 1263
2024
Q4 		$260 Buy
+63
New +$343 ﹤0.01% 1558

Other funds holding RLAY

SB Investment Advisers (UK)
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Caitong International Asset Management's RLAY Position: Q2 2026 in Review

Caitong International Asset Management reduced its Relay Therapeutics (RLAY) stake by 99% in Q2 2026, selling an estimated $40.2K and leaving 22 shares worth $412. The position accounts for ﹤0.01% of the portfolio, ranked #1806.

Caitong International Asset Management first reported a position in RLAY in Q4 2024 and has held it in 5 quarters since. The position peaked at $115K in Q4 2025. 259 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Caitong International Asset Management held 22 shares of Relay Therapeutics worth $412 as of Q2 2026.
  • Caitong International Asset Management sold 2,768 Relay Therapeutics shares in Q2 2026, an estimated $40.2K.
  • Relay Therapeutics made up ﹤0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #1806 holding.
  • Caitong International Asset Management first reported a position in Relay Therapeutics in Q4 2024 and has held it in 5 quarters since.
  • Caitong International Asset Management's Relay Therapeutics position peaked at $115K in Q4 2025.
  • 259 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.